CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-05). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2260 · Search date 2026-08-05 · Methodology v0.6

Family screen restriction,
does it really help with Increased leisure nonsedentary physical activity in children?

30-Second Summary
C
Evidence Grade C · 56 · Safety acceptable
Children became substantially more active during two weeks in which families surrendered devices
No serious adverse event signal was reported over two weeks. Necessary educational, communication, and accessibility use should be separated, with alternative activities and contact methods available to reduce conflict or isolation.
What the
research shows
The grade is C. In a two-week family-cluster trial of 89 families and 181 children, leisure nonsedentary activity increased 45.8 minutes per day more than usual use, 95% CI 27.9-63.6. Activity came from waist and thigh accelerometers, not parent report, and analysis accounted for family clustering. This was still an intensive device-surrender intervention lasting only two weeks in fewer than 200 children.
What the
ads claim
Children averaged 35.9 hours per week of recreational screens at baseline. The exact mean between-group reduction was not reported, but 83 of 86 intervention children stayed at or below seven hours per week, confirmed by tracking apps and TV monitors. This cannot be expanded into proven long-term weight loss or health improvement.
*

Useful facts when choosing a product

  • Intervention families surrendered smartphones and tablets, received basic phones, and targeted no more than three recreational screen hours per person per week.
  • Baseline child recreational use averaged 35.9 hours per week; 83/86 intervention children met the seven-hour adherence threshold, but an exact mean between-group reduction was not reported.
  • Apps tracked phones, tablets, and computers, a current monitor tracked television, and waist and thigh accelerometers measured activity.
Gap Measurement · Verdict 2260 · C 56
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The intervention included 45 families and 86 children; usual-use control included 44 families and 95 children. The primary endpoint was two-week leisure nonsedentary time from combined waist and thigh accelerometry. Change was +44.8±63.5 versus +1.0±55.1 minutes per day; adjusted intention-to-treat difference was +45.8, 95% CI 27.9-63.6, using family random intercepts plus baseline and age adjustment. Recruitment began June 6, 2019, while NCT04098913 was first submitted September 19, making registration retrospective.

02

Why this is classified as C (56)

Family-cluster assignment, objective exposure and activity measurement, a prespecified primary endpoint, and public funding are strengths, but 181 participants and two weeks give C with 56 points.

Counterpoint. This efficacy package combined device surrender, basic-phone loans, household signs, and reimbursement. Ordinary parental advice may not reproduce its adherence or effect.

Rejudgment record. Cross-check applied — Verified family-cluster assignment, random-intercept and baseline-age adjustment, accelerometer outcome, objective adherence, and retrospective registration, while incorporating the two-week and 181-participant limitations

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Increased leisure nonsedentary activity at two weeksCThe difference was +45.8 minutes/day, 95% CI 27.9-63.6.
Increased moderate-to-vigorous activityCA post hoc total-MVPA analysis found +8.8 minutes/day.
Long-term health or weight improvement?Long-term outcomes beyond two weeks were not measured.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Family cluster-randomized clinical trial181Public funding from the European Research Council, UK MRC, and NIHRLeisure nonsedentary time at two weeksAdjusted intention-to-treat +45.8 minutes/day, 95% CI 27.9-63.6Objective prespecified primary outcome
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-05).

Pedersen J, Rasmussen MGB, Sørensen SO, et al. JAMA Pediatr. 2022;176(8):741-749. PMID: 35604678. DOI: 10.1001/jamapediatrics.2022.1519.
checked
ClinicalTrials.gov. NCT04098913. Short-term Efficacy of Reducing Screen-based Media Use.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-05 · Corrections: none

Cite this verdict

Family screen restriction x child physical activity Evidence Grade C card
[Chamgap] Family screen restriction x child physical activity — Evidence Grade C·56. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/sports/family-screen-restriction-child-physical-activity/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.